Biotech Leaders
Hybrid & Decentralized Trials
Complex Clinical Trial Protocol Designs: The Impact on Research Sites and the Role of a Central IRB
Blog Posts
Clinical Trial Quality
WCG Avoca – SOP Review For A Clinical Stage Biopharmaceutical Company
Case Studies
Series: Ask the IRB & IBC Experts
Adults with Limited Capacity to Consent to Research
Blog Posts
Ethics in Clinical Research
What are the requirements for notifications of study closure at research sites?
Blog Posts
Live Survey Results – Part 4: Complex Clinical Trial Protocol Designs: The Effect on Research Sites and the Role Central IRBs Play in Ensuring Quality
Blog Posts
Series: The Future of Clinical Research Sites
Complex Clinical Trial Protocol Designs: The Effect on Research Sites and the Role Central IRBs Play in Ensuring Quality
Videos Expert Endpoint Adjudication and Data Monitoring Committee Solutions Sell Sheet
Solution Overviews
Series: The Future of Clinical Research Sites
Complexities in Coverage Analysis: Getting it Right & Getting it Done
Videos
Ethics in Clinical Research
Can a protocol get IRB approval during the 30-day IND waiting period?
Blog Posts
FDA & ICH